is bpc 157 banned by usada Substances BPC-157: Experimental Peptide Making Strides

Synthetic ERR// agonist induces an ERR-dependent acute aerobic exercise response and enhances exercise capacity

Protocol approach: partial rotator cuff tear Goal: Promote tissue healing, prevent tear progression, avoid surgery if possible Peptide approach: BPC-157: 300 to 500 mcg daily, split doses, local injection near shoulder preferred TB-500: 750 to 1000 mcg twice weekly (loading phase first four weeks), then 500 mcg twice weekly GHK-Cu: 300 to 600 mcg daily from week two onward Duration: Twelve weeks minimum Critical notes: Partial tears require imaging to determine severity and location

While some rat studies raised initial worries, none have shown that BPC-157 directly causes or speeds up cancer development

For example, if a substance has a four-hour half-life, half of the original amount remains after four hours

Previous attempts at treatment and the severity of tissue damage also matter

Headache: Infrequently reported, typically mild